TSS
DGX icon

Two Sigma Securities’s Quest Diagnostics DGX Stock Holding History

Two Sigma Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,600
Closed -$248K – 2023
2024
Q3 		$248K Sell
1,600
-11,200
-88% -$1.67M ﹤0.01% 1953
2024
Q2 		$1.75M Sell
12,800
-20,000
-61% -$2.74M 0.02% 772
2024
Q1 		$4.37M Buy
32,800
+14,400
+78% +$1.87M 0.04% 446
2023
Q4 		$2.54M Buy
18,400
+3,200
+21% +$421K 0.02% 601
2023
Q3 		$1.85M Sell
15,200
-3,700
-20% -$493K 0.02% 721
2023
Q2 		$2.66M Buy
18,900
+11,500
+155% +$1.59M 0.04% 484
2023
Q1 		$1.05M Buy
7,400
+300
+4% +$42.9K 0.02% 819
2022
Q4 		$1.11M Buy
7,100
+1,500
+27% +$216K 0.03% 633
2022
Q3 		$687K Buy
5,600
+1,600
+40% +$211K 0.02% 857
2022
Q2 		$532K Sell
4,000
-3,300
-45% -$450K 0.02% 866
2022
Q1 		$999K Buy
+7,300
New +$1.02M 0.04% 619
2020
Q4 		– Sell
-4,300
Closed -$492K – 1724
2020
Q3 		$492K Buy
4,300
+800
+23% +$94.5K 0.01% 607
2020
Q2 		$399K Sell
3,500
-4,100
-54% -$435K 0.01% 727
2020
Q1 		$610K Buy
7,600
+600
+9% +$62.1K 0.01% 545
2019
Q4 		$748K Sell
7,000
-800
-10% -$83.4K 0.01% 1214
2019
Q3 		$835K Buy
7,800
+5,400
+225% +$554K 0.01% 958
2019
Q2 		$244K Buy
+2,400
New +$231K ﹤0.01% 1582
2019
Q1 		– Sell
-3,000
Closed -$250K – 1931
2018
Q4 		$250K Sell
3,000
-12,900
-81% -$1.21M ﹤0.01% 1532
2018
Q3 		$1.72M Sell
15,900
-27,000
-63% -$2.96M 0.01% 790
2018
Q2 		$4.72M Buy
42,900
+17,000
+66% +$1.77M 0.02% 509
2018
Q1 		$2.6M Buy
+25,900
New +$2.65M 0.01% 740

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Two Sigma Securities's DGX Position: Q1 2026 in Review

Two Sigma Securities reduced its Quest Diagnostics (DGX) stake by 38% in Q1 2026, selling an estimated $177K and leaving 1,490 shares worth $292K. The position accounts for 0.03% of the portfolio, ranked #792.

Two Sigma Securities first reported a position in DGX in Q1 2017 and has held it in 17 quarters since. The position peaked at $1.21M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Two Sigma Securities held 1,490 shares of Quest Diagnostics worth $292K as of Q1 2026.
  • Two Sigma Securities sold 912 Quest Diagnostics shares in Q1 2026, an estimated $177K.
  • Quest Diagnostics made up 0.03% of Two Sigma Securities's portfolio in Q1 2026, its #792 holding.
  • Two Sigma Securities first reported a position in Quest Diagnostics in Q1 2017 and has held it in 17 quarters since.
  • Two Sigma Securities's Quest Diagnostics position peaked at $1.21M in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.